EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial

Birgitte K Andersen, Niels R Holm, Lone J H Mogensen, Luc Maillard, Truls Råmunddal, Andrea Erriquez, Evald H Christiansen, Javier Escaned, On Behalf Of The Favor Iii Europe Study Team

EuroIntervention · 2025-02 · 21 (3) · e161-e170

DOI: 10.4244/eij-d-24-01001 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift EuroIntervention, 2025-02. Verfasst von Birgitte K Andersen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Coronary Artery Disease, Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Safe deferral of revascularisation is a key aspect of physiology-guided percutaneous coronary intervention (PCI). While recent evidence gathered in the FAVOR III Europe trial showed that quantitative flow ratio (QFR) guidance did not meet non-inferiority to fractional flow reserve (FFR) guidance, it remains unknown if QFR might have a specific value in revascularisation deferral. AIMS: We aimed to evaluate the safety of coronary revascularisation deferral based on QFR as compared with FFR. METHODS: Patients randomised in the FAVOR III trial in whom PCI was deferred in at least one coronary artery, based on QFR or FFR>0.80, were included in the present substudy. The primary outcome was the 1-year rate of major adverse cardiac events (MACE), with results reported for two subsets of deferred patients: (1) any study lesion deferral and (2) complete study lesion deferral. RESULTS: A total of 523 patients (55.2%) in the QFR group and 599 patients (65.3%) in the FFR group had at least one coronary revascularisation deferral. Of these, 433 patients (82.8%) and 511 (85.3%) patients, respectively, had complete study lesion deferral. In the "complete study lesion deferral" patient group, the occurrence of MACE was significantly higher in QFR-deferred patients as compared with FFR-deferred patients (24 [5.6%] vs 14 [2.8%], adjusted hazard ratio [HR] 2.07, 95% confidence interval [CI]: 1.07-4.03; p=0.03). In the subgroup of "any study lesion deferral", the MACE rate was 5.6% vs 3.6% (QFR vs FFR), adjusted HR 1.55, 95% CI: 0.88-2.73; p=0.13. CONCLUSIONS: QFR-based deferral of coronary artery revascularisation resulted in a higher incidence of 1-year MACE as compared with FFR-based deferral.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseFractional Flow Reserve, MyocardialPercutaneous Coronary InterventionAgedFemaleHumansMaleMiddle AgedCoronary AngiographyEuropeTreatment Outcome

Autor:innen und Institutionen

  • Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • GCS ES Axium Rambot, Clinique Axium, Aix-en-Provence, France.
  • Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.
  • Hospital Clínico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain and Centro de Investigación Biomédica en Red - Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.

Zitieren

APA

Andersen, B. K., Holm, N. R., Mogensen, L. J. H., Maillard, L., Råmunddal, T., Erriquez, A., Christiansen, E. H., Escaned, J., & Of The Favor Iii Europe Study Team, O. B. (2025). Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial. EuroIntervention, 21(3), e161-e170. https://doi.org/10.4244/eij-d-24-01001

Vancouver

Andersen BK, Holm NR, Mogensen LJH, Maillard L, Råmunddal T, Erriquez A, et al. Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial. EuroIntervention. 2025;21(3):e161-e170. doi:10.4244/eij-d-24-01001

BibTeX
@article{Andersen2025,
  author = {Andersen, Birgitte K and Holm, Niels R and Mogensen, Lone J H and Maillard, Luc and Råmunddal, Truls and Erriquez, Andrea and Christiansen, Evald H and Escaned, Javier and Of The Favor Iii Europe Study Team, On Behalf},
  title = {Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial},
  journal = {EuroIntervention},
  year = {2025},
  volume = {21},
  number = {3},
  pages = {e161--e170},
  doi = {10.4244/eij-d-24-01001}
}
Kostenlos starten →